Chapter

Combination therapy for the management of hyperlipidaemia

Anthony S. Wierzbicki

in Hyperlipidaemia

Published on behalf of Oxford University Press

ISBN: 9780199543502
Published online October 2011 | e-ISBN: 9780199607204 | DOI: http://dx.doi.org/10.1093/med/9780199543502.003.0009

Series: Oxford Cardiology Library

Combination therapy for the management of hyperlipidaemia

Show Summary Details

Preview

• Low doses of multiple drugs can be combined to treat patients intolerant to statin therapy • Combination therapy to reduce LDL-C is increasingly necessary to reduce LDL-C >; 50% as required in the highest risk patients • Statins have little effect on risk driven by low HDL-C and increasingly niacin (nicotinic acid) and fibrates are used in combination with statins to optimize the total lipid profile • Large-scale end point studies with statin-other drug combinations are underway.

Chapter.  2468 words. 

Subjects: Cardiovascular Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.